Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 9, 2011, Pages 1176-1186

  Sapey, Elizabeth ^a   Stockley, James A ^a   Greenwood, Hannah ^a   Ahmad, Ali ^a   Bayley, Darren ^b   Lord, Janet M ^a   Insall, Robert H ^c   Stockley, Robert A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Chemokines; Chemotaxis; Neutrophils; Obstructive lung disease; Smoking

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8;

ACCURACY; ADULT; AGED; ARTICLE; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO SELECTION; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PHOTOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPODIUM; SMOKING; SPUTUM;

ADULT; AGED; CHEMOKINE CXCL1; CHEMOTAXIS; CHROMONES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; MORPHOLINES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SPUTUM;

EID: 79955487961     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201008-1285OC     Document Type: Article

References (60)

1. World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet 315 (accessed July 15, 2010). Available from: www.whoint/mediacentre/ factsheet/fs315/en/index.html
2. Mannino DM, Holguin F. Epidemiology and global impact of obstructive pulmonary disease. Respir Med 2006;1:114-120.
3. Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in copd. Eur Respir J 2000;15:109-115. (Pubitemid 30068945)
4. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996;51:267-271.
5. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Ohlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Chracterization and correlation with clinical parameters. Am Rev Respir Dis 1989;140:1527-1537.
6. Pilette C, Colinet B, Kiss R, Andre S, Kaltner H, Gabius HJ, Delos M, Vaerman JP, Decrmer M, Sibelle Y. Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe chronic obstructive pulmonary disease. Eur Respir J 2007;29:914-922. (Pubitemid 46711895)
7. Donaldson GC, Seemungal TA, Patal IS, Bhowmik A, Wilkinson TM, Hurst JR, MacCallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005;128:1995-2004. (Pubitemid 41507533)
8. Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA. Inflammation in sputum relates to progression of disease in COPD: a prospective study. Respir Res 2006;7:136.
9. Yoshioka A, Betsuyaku T, Nishimura M, Miyamoto K, Kondo T, Kawakami Y. Excessive neutrophil elastase in bronchoalveolar lavage fluid from patients with sub-clinical emphysema. Am J Respir Crit Care Med 2005;152:2127-2132.
10. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151S-155S.
11. Snider GL, Hayes JA, Franzblau C, Kagan HM, Stone PJ, Korthy A. Relationship between elasteolytic activity and experimental emphysema inducing properties of papain preparations. Am Rev Respir Dis 1974;110:254-257.
12. Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallahnejad M, Weinbaum G. Immunolocalisation of elastase in human emphysematous lungs. J Clin Invest 1986;78:482-493. (Pubitemid 16074086)
13. Smallman LA, Hill SL, Stockley RA. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax 1984;39:663-667. (Pubitemid 14059514)
14. Aoshiba K, Yasuda K, Yasui S, Tamaoki J, Nagai A. Serine proteinases increase oxidative stress in lung cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L556-L564.
15. Nakajoh M, Fukushima T, Suzuki K, Yamaya M, Nakayama K, Sekizawa K, Sasaki H. Retinoic acid inhibits elastase-induced injury in human lung epithelial cells. Am J Respir Cell Mol Biol 2002;28:296-304.
16. Shao MX, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells. Proc Natl Acad Sci USA 2005;102:767-772. (Pubitemid 40282740)
17. Takeyabu K, Agusti C, Ueki IF, Lausier J, Cardell LO, Nadel JA. Neutrophil-dependent goblet cell degranulation: role of membrane bound elastase and adhesion molecules. Am J Physiol 1998;19:L294-L302.
18. Rytila P, Plataki M, Bucchieri F, Uddin M, Nong G, Kinnula VL, Djukanovic D. Airway neutrophilia in COPD is not associated with increased neutrophil survival. Eur Respir J 2006;28:1163-1169. (Pubitemid 44883851)
19. Uller L, Persson CG, Erjefalt JS. Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both. Trends Pharmacol Sci 2006;27:461-466. (Pubitemid 44251226)
20. Burnett D, Chamba A, Hill SL, Stockley RA. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987;2:1043-1046. (Pubitemid 17154783)
21. Woolhouse IS, Bayley DL, Lalor P, Adams DH, Stockley RA. Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease. Eur Respir J 2005;25:612-617. (Pubitemid 40528752)
22. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001;56:432-437. (Pubitemid 32521359)
23. Yoshikawa T, Dent G, Ward J, Angco G, Nong G, Nomura N, Hirata K, Djukanovic R. Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:473-479. (Pubitemid 46354251)
24. Fulop T, Larbi A, Douziech N, Fortin CF, Guerard KP, Lesur O, Khalil A, Dupuis G. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004;3:217-226. (Pubitemid 40246686)
25. Andrew N, Insall R. Chemotaxis in shallow gradients is mediated independently of PtdIns-3-kinase by biased choices between random protrusions. Nat Cell Biol 2007;9:193-200.
26. Sapey E, Ahmad A, Bayley D, Insall RH, Stockley RA. Aberrant chemotaxis of blood neutrophils in COPD: correcting the abnormality [abstract]. Am J Respir Crit Care Med 2009;179:A5191.
27. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, Committee GS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276. (Pubitemid 32378468)
28. Mikami M, Llewellyn-Jones CG, Bayley D, Stockley RA. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998;157:723-728.
29. Zicha D, Dunn GA, Brown AF. A new direct-viewing chemotaxis chamber. J Cell Sci 1991;99:769-775.
30. Sapey E, Wood AM, Ahmad A, Stockley RA. TNF alpha rs361525 polymorphism is associated with increased local production and downstream inflammation in COPD. Am J Respir Crit Care Med 2010;180:192-199.
31. British Thoracic Society. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994;88:165-194.
32. Turato G, Di Stefano A, Maestrelli P, Mapp CE, Ruggieri MP, Roggeri A, Fabbri LM, Saetta M. Effect of smoking cessation on airway inflammation in chronic bronchitis. Am J Respir Crit Care Med 1995; 152:1262-1267.
33. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006;28:346-351. (Pubitemid 44914234)
34. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell surface bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 1995;131: 775-789.
35. Campbell EJ, Campbell MA, Owen CA. Bioactive proteinase three on the cell surface of human neutrophils: quantification, catalytic activity and susceptibility to inhibition. J Immunol 2000;165:3366-3374.
36. Owen CA, Campbell MA, Boukedes SS, Campbell EJ. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. Am J Physiol Lung Cell Mol Physiol 1997;272:L385-L393.
37. Cepinskas G, Sandig M, Kvietys PR. PAF-induced elastase dependent neutrophil transendothelial migration is associated with the mobilisation of elastase to the neutrophil surface and localised to the migrating front. J Cell Sci 1999;112:1937-1945. (Pubitemid 29338818)
38. Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol 1996;157:2624-2631. (Pubitemid 126450478)
39. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88:891-897.
40. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 1997;402:111-115. (Pubitemid 27078240)
41. Traves SL, Smith SJ, Barnes PJ, Dinelly LE. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD. A role for CXCR2. J Leukoc Biol 2004;76:441-450. (Pubitemid 39006959)
42. Weber I. Is there a pilot in a pseudopod? Eur J Cell Biol 2006;85:915-924.
43. Zhelev DV, Alteraifi AM, Chodniewicz D. Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants. Biophys J 2004;87:688-695. (Pubitemid 38880121)
44. Levine H, Kessler DA, Rappel WJ. Diectional chemotaxis: a balanced inactivation model. Proc Natl Acad Sci USA 2006;26:9761-9766. (Pubitemid 43993571)
45. Jin T, Xu X, Fang J, Isik N, Yan J, Brzostowski JA, Hereld D. How human leucocytes track down and destroy pathogens: lessons learned from the model organism Dictyostelium discoideum. Immunol Res 2009;43:118-127.
46. Hannigan M, Zhan L, Li Z, Ai Y,Wu D, Huang CK. Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc Natl Acad Sci USA 2002;99:3603-3608. (Pubitemid 34252153)
47. Wu D. Signaling mechanisms for regulation of chemotaxis. Cell Res 2005;15:52-56. (Pubitemid 41653966)
48. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001;53:1-24. (Pubitemid 32173106)
49. Sadhu C, Masinovsky B, Dick K, Sowell G, Staunton DE. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 2003;170:2647-2654. (Pubitemid 36245657)
50. Eddy RJ, Plerinl LM, Matsumura F, Maxfield FR. Ca21 dependent myosin II activation is required for uropod retraction during neutrophil migration. J Cell Sci 2000;113:1287-1296.
51. Fais S, Malorni W. Leukocyte uropod formation and membrane/ cytoskeleton linkage in immune interactions. J Leukoc Biol 2003;73: 556-563. (Pubitemid 38040467)
52. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 2007;404:15-21. (Pubitemid 46788080)
53. Saetta M, Turato G, Maestrelli P, Ciaccia A, Fabbri LM. Cellular and structural basis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-1309. (Pubitemid 32506590)
54. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002;283:L867-L873.
55. Chapman HAJ, Stone OL. Comparison of live human neutrophil and alveolar macrophage elastolytic activity in vitro. Relative resistance of macrophage elastolytic activity to serum and alveolar proteinase inhibitors. J Clin Invest 1984;74:1693-1700. (Pubitemid 15214081)
56. Itoh Y, Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 1995;270:16518-16521.
57. Wright JL, Farmer SG, Churg A. Synthetic serine elastase inhibitor reduces cigarette smoke induced emphysema in guinea pigs. Am J Respir Crit Care Med 2002;166:954-960. (Pubitemid 35193225)
58. Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, Chen Q, Homer RJ, Wang J, Rabach LA, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest 2002;110:463-474. (Pubitemid 34919700)
59. Taylor AE, Finney-Hayward TK, Quint JK, Thomas CMR, Tudhope SJ, Wedzicha JA, Barnes PJ, Donnelly LE. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010;35:1039-1047.
60. Valerius NH, Stendahl O, Hartwig JH, Stossel TP. Distribution of actinbinding protein and myosin in polymorphonuclear leukocytes during locomotion and phagocytosis. Cell 1981;24:195-202. (Pubitemid 11157144)